Skip to main content

Table 2 Dup15q syndrome participant characteristics (longitudinal study)

From: Properties of beta oscillations in Dup15q syndrome

Participant

Duplication type

Visit 1 Age (months)

Visit 2 Age (months)

Epilepsy (active)

Medications

P1

Isodicentric

57

72

No

N/A

P2

Isodicentric

18

28

Yes (at second visit)

Vigabatrin (at second visit)

P3

Interstitial

51

78

No

N/A

P4

Isodicentric

110

134

No

N/A

P5

Isodicentric

84

100

Yes (at both visits)

Carbamazepine; levetiracetam (unchanged at both visits)

P6

Interstitial

48

72

No

N/A

P7

Isodicentric

29

53

Yes (at second visit)

Lamotrigine (at second visit)

P8

Isodicentric

38

61

Yes (at both visits)

Valproate, clobazam, lacosamide, perampanel (unchanged at both visits)

P9

Interstitial

44

68

No

N/A

P10

Interstitial

161

185

No

N/A

  1. N/A not available. Dosages were not available for all the medications listed, hence not included in the table